Published in
Elsevier, Clinical Lymphoma, Myeloma and Leukemia, 8(22), p. e751-e761, 2022
DOI: 10.1016/j.clml.2022.04.005
Links
Tools
Isatuximab-Pomalidomide-Dexamethasone Versus Pomalidomide-Dexamethasone in East Asian Patients With Relapsed/Refractory Multiple Myeloma: ICARIA-MM Subgroup Analysis
Journal article published in 2022 by
Kazutaka Sunami 
,
Takashi Ikeda ,
Shang-Yi Huang,
Ming-Chung Wang,
Youngil Koh,
Chang Ki Min,
Su-Peng Yeh,
Morio Matsumoto,
Michihiro Uchiyama,
Satoshi Iyama,
Chihiro Shimazaki,
Jae Hoon Lee,
Kihyun Kim,
Hitomi Kaneko,
Jin Seok Kim
and other authors.
,
Takashi Ikeda ,
Shang-Yi Huang,
Ming-Chung Wang,
Youngil Koh,
Chang Ki Min,
Su-Peng Yeh,
Morio Matsumoto,
Michihiro Uchiyama,
Satoshi Iyama,
Chihiro Shimazaki,
Jae Hoon Lee,
Kihyun Kim,
Hitomi Kaneko,
Jin Seok Kim
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 